RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

被引:54
|
作者
Hoette, Susana [1 ]
Creuze, Nicolas [2 ]
Gunther, Sven [3 ]
Montani, David [3 ]
Savale, Laurent [3 ]
Jais, Xavier [3 ]
Parent, Florence [3 ]
Sitbon, Olivier [3 ]
Rochitte, Carlos Eduardo [4 ]
Simonneau, Gerald [3 ]
Humbert, Marc [3 ]
Souza, Rogerio [1 ]
Chemla, Denis [2 ]
机构
[1] Univ Sao Paulo, Inst Heart, Dept Pulm, Sch Med, Ave Dr Eneas de Carvalho Aguiar,44, BR-05403000 Sao Paulo, Brazil
[2] APHP, Physiol & Radiol, Fac Med Paris 11, EA4533, Le Kremlin Bicetre, France
[3] Paris11 Univ, APHP, Pneumol, Inserm,UMR S999, Le Kremlin Bicetre, France
[4] Univ Sao Paulo, Inst Heart, Cardiovasc Imaging, Sch Med, Sao Paulo, Brazil
关键词
Right ventricular dysfunction; Pulmonary hypertension; Cardiac ventricles; Hemodynamics; RVFAC; TAPSE; CARDIAC MAGNETIC-RESONANCE; TRICUSPID ANNULAR MOTION; ARTERIAL-HYPERTENSION; THERAPY; HEMODYNAMICS; PRESSURE; SURVIVAL; MRI;
D O I
10.1007/s00408-018-0089-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The right ventricular ejection fraction (RVEF) is a surrogate marker of right ventricular function in pulmonary hypertension (PH), but its measurement is complicated and time consuming. The tricuspid annular plane systolic excursion (TAPSE) measures only the longitudinal component of RV contraction while the right ventricular fractional area change (RVFAC) takes into account both the longitudinal and the transversal components. The aim of our study was to evaluate the relationship between RVEF, RVFAC, and TAPSE according to hemodynamic severity in two groups of patients with PH: pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Fifty-four patients with PAH (n = 15) and CTEPH (n = 39) underwent right heart catheterization and cardiac magnetic resonance (CMR). The ventricular volumes and areas, TAPSE, and eccentricity index were measured. The RVFAC was more strongly correlated with the RVEF (r = 0.81, p < 0.0001) than the TAPSE (r = 0.63, p < 0.0001). RVEF < 35% was better predicted by the RVFAC than the TAPSE (TAPSE: AUC = 0.77 and RVFAC: AUC = 0.91; p = 0.042). In the group with the worse hemodynamic status, the RVFAC correlated much better with the RVEF than the TAPSE. There were no significant differences in the CMR data analyzed between the groups of PAH and CETPH patients. The RVFAC is a good index to estimate RVEF in PH patients; even better than the TAPSE in patients with more severe hemodynamic profile, possibly for including the transversal component of right ventricular function in its measurement. Furthermore, RVFAC performance was similar in the two PH groups (PAH and CTEPH).
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [21] Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Caputo, Annalisa
    Papa, Silvia
    Manzi, Giovanna
    Laviola, Domenico
    Recchioni, Tommaso
    Severino, Paolo
    Lavalle, Carlo
    Maestrini, Viviana
    Mancone, Massimo
    Badagliacca, Roberto
    Vizza, Carmine Dario
    CURRENT HEART FAILURE REPORTS, 2023, 20 (04) : 263 - 270
  • [22] Recognizing Pulmonary Hypertension and Right Ventricular Dysfunction in Heart Failure
    Lala, Anuradha
    Pinney, Sean P.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 58 (04) : 416 - 424
  • [23] The strain-encoded (SENC) MR imaging for detection of global right ventricular dysfunction in pulmonary hypertension
    Oyama-Manabe, Noriko
    Sato, Takahiro
    Tsujino, Ichizo
    Kudo, Kohsuke
    Manabe, Osamu
    Kato, Fumi
    Osman, Nael F.
    Terae, Satoshi
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2013, 29 (02) : 371 - 378
  • [24] Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease
    Prins, Kurt W.
    Rose, Lauren
    Archer, Stephen L.
    Pritzker, Marc
    Weir, E. Kenneth
    Olson, Matthew D.
    Thenappan, Thenappan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (02):
  • [25] Con: Preinduction Pulmonary Artery Catheter Placement Is Advisable in Patients With Right Ventricular Dysfunction Secondary to Severe Pulmonary Hypertension
    Hargrave, Jennifer
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2017, 31 (04) : 1514 - 1518
  • [26] Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension)
    Wilson, Sean R.
    Ghio, Stefano
    Scelsi, Laura
    Horn, Evelyn M.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 55 (02) : 104 - 118
  • [27] CMR validation of fractional changes in annulo-apical angles and TAPSE for rapid assessment of right ventricular systolic function
    Simon A Zakeri
    Alexander Borg
    Matthias Schmitt
    Journal of Cardiovascular Magnetic Resonance, 14 (Suppl 1)
  • [28] Do Electrocardiography Scores Predict the Presence of Right Ventricular Dysfunction in Patients with Pulmonary Hypertension?
    Abe, Kohtaro
    INTERNAL MEDICINE, 2012, 51 (17) : 2261 - 2262
  • [29] Prognostic Effects of Changes in Right Ventricular Fractional Area Change in Patients With Heart Failure
    Sugawara, Yukiko
    Yoshihisa, Akiomi
    Takeishi, Ryohei
    Ohara, Himika
    Anzai, Fumiya
    Hotsuki, Yu
    Watanabe, Koichiro
    Sato, Yu
    Abe, Satoshi
    Misaka, Tomofumi
    Sato, Takamasa
    Oikawa, Masayoshi
    Kobayashi, Atsushi
    Nakazato, Kazuhiko
    Takeishi, Yasuchika
    CIRCULATION JOURNAL, 2022, 86 (12) : 1982 - 1989
  • [30] Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension
    Rosenberg, Mark
    Meyer, F. Joachim
    Gruenig, Ekkehard
    Lutz, Matthias
    Lossnitzer, Dirk
    Wipplinger, Rita
    Katus, Hugo A.
    Frey, Norbert
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (09) : 933 - 942